GEN Exclusives

More »

GEN News Highlights

More »
Feb 1, 2007

Althea and Blueshift Combine Technologies for Gene Expression Screening

  • Althea Technologies and Blueshift Biotechnologies report that Althea received a SBIR award from the NHGRI to explore the potential for practical high-throughput and low-cost gene expression analysis.

    The grant proposes the development of gene expression profiling methods that make use of Althea's technology in multiplexed PCR (XP™-PCR)* methods and Blueshift's IsoCyte™ platform. This platform is a high-throughput laser scanner adapted from semiconductor inspection technology that provides multicolor fluorescence, anisotropy, and scatter images for high-content and object-based multiplexed array formats.

    The combined technologies may enable implementation of quantitative gene expression profiling in an automated high-throughput platform, providing highly specific and quantitative results for as many as 768 samples per minute.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Disclosing Clinical Trial Data

Do you believe that conducting performance audits for new drugs will incentivize pharma firms to become more transparent?

More »